We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
High throughput siRNA Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical NF-kB Activation Pathway
News

High throughput siRNA Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical NF-kB Activation Pathway

High throughput siRNA Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical NF-kB Activation Pathway
News

High throughput siRNA Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical NF-kB Activation Pathway

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "High throughput siRNA Screening of the Human Kinome Identifies Novel Kinases Controlling the Canonical NF-kB Activation Pathway"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Abstract
Nuclear Factor-κB (NF-κB) is an inducible cytoplasmic transcription factor that plays a role as a master regulator of airway mucosal inflammation. The prototypical (canonical) NF-κB pathway controls cytoplasmic to nuclear translocation in response to stimulation by the mononuclear cytokine, TNF. Despite intensive investigation, the spectrum of kinases involved in the canonical NF-κB pathway has not yet been systematically determined. Here we have applied a high throughput-siRNA (HT-siRNA)-mediated loss-of-function screening assay to identify novel kinases important in TNF-induced NF-κB signaling. Type II A549 epithelial cells stably expressing an IL-8/Luciferase reporter gene optimized for HT-siRNA format (Z prime score of 0.65) and siRNAs for 636 human kinases were reverse-transfected and screened in the assay. 36 candidate genes were identified that inhibited TNF signaling with a z score deviation of <-1.3 in replicate plates. From this group, 11 kinases were selected for independent validation, of which 8 were successfully silenced. Six kinases were validated, including ATM, CDK2,-5 and -7, CALM3, MAPAKP5, and MAP3K/MEKK3. The surprising function of ATM in TNF signaling was confirmed where reduced NF-kB/RelA translocation and Ser 276 phosphorylation was seen in ATM(-/-)MEFs. These data indicate that ATM is a key regulatory kinase that may control global NF-κB activation in the TNF-induced canonical pathway.

The article is published online in the Journal of Biological Chemistry and is free to access.

Advertisement